Literature DB >> 6434534

Primary structure of human triosephosphate isomerase.

H S Lu, P M Yuan, R W Gracy.   

Abstract

Human placental triosephosphate isomerase was isolated by an improved procedure and recovered with the highest specific activity ever reported. Employing this purification procedure, sufficient amounts of the enzyme were obtained for detailed primary structural studies. For sequences analysis, the enzyme was reduced and carboxymethylated and subjected to tryptic and chymotryptic digestions. The peptide mixtures were separated by high-performance liquid chromatography using octyl or alkylphenyl reverse-phase columns and trifluoroacetic acid/acetonitrile gradient elution systems. Sequence analyses of the intact enzyme, tryptic, chymotryptic, and cyanogen bromide peptides were accomplished using high-sensitivity solid-phase sequencing procedures with either 4-N,N-dimethylaminoazobenzene-4'-isothiocyanate or phenylisothiocyanate. The primary structure of human triosephosphate isomerase is constructed from the alignment of the tryptic peptides with the analysis of the overlapping chymotryptic peptides. The enzyme is a dimeric molecule consisting of two identical polypeptide chains with 248 amino acid residues and a calculated subunit molecular mass of 26,750 daltons. A comparison of the amino acid sequences from the human placental enzyme and from other species such as rabbit, chicken, and coelacanth muscles showed relatively high sequence homology, indicating that the evolution of the enzyme is very conservative. The amino acids of the active-site pocket and the subunit-subunit contact sites exhibit few changes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434534

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.

Authors:  F Orosz; G Wágner; K Liliom; J Kovács; K Baróti; M Horányi; T Farkas; S Hollán; J Ovádi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells.

Authors:  J Zhang; L E Maquat
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  Searching sequence space by definably random mutagenesis: improving the catalytic potency of an enzyme.

Authors:  J D Hermes; S C Blacklow; J R Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Control of oligomeric enzyme thermostability by protein engineering.

Authors:  T J Ahern; J I Casal; G A Petsko; A M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family.

Authors:  J R Brown; I O Daar; J R Krug; L E Maquat
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

6.  Genetic engineering in the Precambrian: structure of the chicken triosephosphate isomerase gene.

Authors:  D Straus; W Gilbert
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

7.  Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy.

Authors:  Alicia M Celotto; Adam C Frank; Jacquelyn L Seigle; Michael J Palladino
Journal:  Genetics       Date:  2006-09-15       Impact factor: 4.562

8.  Origin of human triosephosphate isomerase isozymes: further evidence for the single structural locus hypothesis with Japanese variants.

Authors:  J Asakawa; S Iida
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Hominoid triosephosphate isomerase: characterization of the major cell proliferation specific isozyme.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Mol Cell Biochem       Date:  1986-06       Impact factor: 3.396

10.  Premature translation termination mediates triosephosphate isomerase mRNA degradation.

Authors:  I O Daar; L E Maquat
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.